Cell Therapy Market Research Report by Cell Type (Differentiated Cell and Stem Cell), by Therapy Type (Allogenic Therapies and Autologous Therapies), by Application, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19
The Global Cell Therapy Market is expected to grow from USD 4,502.02 Million in 2019 to USD 7,927.62 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.88%.
Market Segmentation & Coverage: This research report categorizes the Cell Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Cell Type, the Cell Therapy Market studied across Differentiated Cell and Stem Cell.
Based on Therapy Type, the Cell Therapy Market studied across Allogenic Therapies and Autologous Therapies.
Based on Application, the Cell Therapy Market studied across Autoimmune Diseases, Dermatology, Muscoskeletal Therapies, and Oncology.
Based on End-User, the Cell Therapy Market studied across Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, and Research Institutes.
Based on Geography, the Cell Therapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Therapy Market including ANTEROGEN.CO., LTD, Celgene Corporation, JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., NuVasive, Inc, Osiris Therapeutics, Inc., Stemedica Cell Technologies, Inc., and Vericel Corporation.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Cell Therapy Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Therapy Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Therapy Market? 4. What is the competitive strategic window for opportunities in the Global Cell Therapy Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Therapy Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Therapy Market?
Our reports have been used by over 10K customers, including:
Hepatocyte Growth Factor - Pipeline Review, H2 2020 Summary According to the recently published report ’Hepatocyte Growth Factor - Pipeline Review, H2 2020’; Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. Hepatocyte Growth...
349 pages •
By Global Industry Analysts
• Oct 2020
Growing Value of Stem Cells in Medicine to Create a US$2.4 Billion Opportunity for Induced Pluripotent Stem Cell ((iPSC) The global market for Induced Pluripotent Stem Cell ((iPSC) is projected to reach US$2.4 billion by the year 2027, trailing a post COVID-19 CAGR of 6.6%, over the analysis period 2020 through 2027. Stem cells are...
The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications. In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative...
Alpha L-Iduronidase - Pipeline Review, H2 2020 Summary Alpha L-Iduronidase (IDUA or EC 22.214.171.124) - Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene...
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical...
The global cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, large number of oncology-related...
The North America cell therapy instruments market was valued at US$ 5,546.84 million in 2019 and is projected to reach US$ 14,806.33 million by 2027; it is expected to grow at a CAGR of 13.4% during the forecast period. The surge in the number of cell therapy transplantation procedures, growing research and development activities, and rising...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.